Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ARWR [NASD]
Arrowhead Research Corp.
Index- P/E- EPS (ttm)-1.08 Insider Own0.70% Shs Outstand52.91M Perf Week-8.94%
Market Cap344.97M Forward P/E- EPS next Y-0.74 Insider Trans4.52% Shs Float52.41M Perf Month-53.16%
Income-49.90M PEG- EPS next Q-0.24 Inst Own75.10% Short Float23.23% Perf Quarter-44.56%
Sales0.20M P/S1724.87 EPS this Y31.60% Inst Trans-1.30% Short Ratio2.62 Perf Half Y-40.51%
Book/sh3.59 P/B1.82 EPS next Y29.50% ROA-45.70% Target Price17.75 Perf Year-6.86%
Cash/sh3.06 P/C2.13 EPS next 5Y7.33% ROE-49.60% 52W Range5.47 - 27.63 Perf YTD-39.91%
Dividend- P/FCF- EPS past 5Y28.30% ROI-82.60% 52W High-76.40% Beta2.80
Dividend %- Quick Ratio19.70 Sales past 5Y-25.40% Gross Margin- 52W Low19.20% ATR0.79
Employees54 Current Ratio19.70 Sales Q/Q- Oper. Margin- RSI (14)26.86 Volatility6.07% 14.73%
OptionableYes Debt/Eq0.01 EPS Q/Q4.30% Profit Margin- Rel Volume0.64 Prev Close6.73
ShortableYes LT Debt/Eq0.00 EarningsNov 10 AMC Payout- Avg Volume4.65M Price6.52
Recom2.00 SMA20-15.14% SMA50-46.49% SMA200-54.09% Volume2,971,194 Change-3.12%
09-Oct-14Downgrade RBC Capital Mkts Outperform → Sector Perform $35 → $9
05-Mar-14Initiated RBC Capital Mkts Outperform $35
05-Mar-14Initiated Deutsche Bank Buy $45
26-Feb-13Initiated Dawson James Buy $4
27-Oct-14 04:49PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR Marketwired
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
07:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Arrowhead Research Corporation of Class Action Lawsuit and Upcoming Deadline -- ARWR GlobeNewswire
24-Oct-14 03:22PM  EQUITY ALERT: Rosen Law Firm Reminds Arrowhead Research Corp. Investors of Important Deadline in Class Action Filed by Firm - ARWR GlobeNewswire
23-Oct-14 10:03AM  Morgan & Morgan Reminds Investors That a Class Action Lawsuit Has Been Filed Against Arrowhead Research Corporation -- ARWR GlobeNewswire
22-Oct-14 03:52PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Arrowhead Research Corp. To Contact Brower Piven Before The December 9, 2014 Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
20-Oct-14 12:40PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 -- ARWR GlobeNewswire
17-Oct-14 11:49AM  ARROWHEAD RESEARCH CORP. SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Arrowhead Research Corp. GlobeNewswire -8.12%
09:41AM  5 Stocks Under $10 Set to Soar at TheStreet
15-Oct-14 10:18PM  Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Has Been Filed in the Central District of California Against Arrowhead Research Corporation -- ARWR GlobeNewswire +10.03%
05:23PM  Lifshitz & Miller Law Firm Announces Investigation of Apco Oil & Gas International Inc., Arrowhead Research Corporation, Auxilium Pharmaceuticals, Inc., EveryWare Global, Inc., and Gentiva Health Services, Inc. PR Newswire
04:10PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Arrowhead Research Corp. to Contact Brower Piven Before the December 9, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- AR GlobeNewswire
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm Marketwired
11:22AM  Arrowhead Research Corp. Stockholders Who Suffered Losses in Excess of $100,000 Encouraged to Contact Securities Law Firm about Investigation PR Newswire
14-Oct-14 06:36PM  SHAREHOLDER ALERT: Class Action Lawsuit Against Arrowhead Research Corporation Filed By Glancy Binkow & Goldberg LLP Business Wire
12:45PM  Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Arrowhead Research Corporation PR Newswire
11:29AM  Arrowhead Research Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
13-Oct-14 06:38PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Arrowhead Research Corporation and Certain Officers -- ARWR GlobeNewswire -5.34%
06:13PM  Robbins Arroyo LLP: Arrowhead Research Corporation (ARWR) Misled Shareholders According to a Recently Filed Class Action GlobeNewswire
04:00PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Arrowhead Research Corp. (ARWR) To Contact The Firm PR Newswire
11:14AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Arrowhead Research Corp. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2014 Business Wire
10-Oct-14 05:25PM  EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Arrowhead Research Corp. -- ARWR GlobeNewswire -7.95%
06:05AM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09-Oct-14 12:15PM  ARWR: Efficacy of ARC-520 Phase IIa not as Strong as Expected, But the Program Is still Viable Zacks Small Cap Research
11:37AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arrowhead Research Corp. - ARWR PR Newswire
08:30AM  Arrowhead Issues Open Letter to Shareholders Business Wire
07:54AM  ARROWHEAD SHAREHOLDER ALERT -- National Securities Law Firm Announces Investigation Of Arrowhead For Potential Violations Of Federal Securities Laws. Encourages Shareholders To Contact Law Firm For More Information. PR Newswire
06:38AM  Arrowhead Research downgraded by RBC Capital Mkts Briefing.com
01:13AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Arrowhead Research Corp. - ARWR Business Wire
08-Oct-14 05:50PM  [video] Arrowhead oversold: Analyst at CNBC -43.80%
04:47PM  Fed to the rescueagain! Yahoo Finance Blogs
03:52PM  Blame Arrowhead Management Entirely for Today's Epic Collapse at TheStreet
02:32PM  Arrowhead Research Corp Hammered On Drug News; Deutsche Bank Lowers Price Target Benzinga
01:49PM  Midday Losers From October 8 - Arrowhead Research Corp, A10 Networks Inc. And More Benzinga
01:36PM  Merck, Bristol, Arrowhead Prep Hepatitis Studies at Investor's Business Daily
10:38AM  Arrowhead Research Sinks on Disappointing Hepatitis B Drug Data at TheStreet
10:00AM  Arrowhead to Present ARC-520 Phase 2a Data in Late-Breaking Session at AASLD Liver MeetingĀ® 2014 Business Wire
07-Oct-14 07:30AM  Arrowhead to Present at 10th Annual Meeting of the Oligonucleotide Therapeutics Society Business Wire -7.26%
06-Oct-14 02:28PM  Top 5 Biotech Stocks Over The Past Year Benzinga
30-Sep-14 07:30AM  Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs Business Wire
19-Sep-14 02:00PM  Arrowhead to Present at BioCenturys NewsMakers in the Biotech Industry Conference Business Wire
11-Sep-14 01:47PM  3 Biotech Breakout Charts That Could See More Upside Next Week at TheStreet
04-Sep-14 02:51PM  Arrowhead Research Corp Heads Higher After Breakout Benzinga
03-Sep-14 01:41PM  Arrowhead Research Climbs +8.54% Midday, Is Up Over +50% YTD at TheStreet +6.06%
12:54PM  Arrowhead Research Corp Shares Push Over Resistance Level As Momentum Continues Benzinga
02-Sep-14 10:48AM  5 Stocks Poised for Big Breakouts at TheStreet +5.28%
26-Aug-14 04:02PM  Winners & Losers From Tuesday, August 26 Benzinga +13.10%
02:24PM  Arrowhead Research (ARWR) Stock Rises on High Volume at TheStreet
01:31PM  Nasdaq stocks posting largest percentage increases AP
05:00AM  'Fast Money' Recap: Next Stop, S&P 2,100? at TheStreet
25-Aug-14 05:00PM  [video] $8.3 billion biotech deal at CNBC
19-Aug-14 01:04PM  ARROWHEAD RESEARCH CORP Financials EDGAR Online Financials
06:30AM  5 Stocks Jumping on Unusual Volume at TheStreet
18-Aug-14 07:30AM  ARWR: Arrowhead Reported Fiscal 2014 Third Quarter Financial Results with a Strong Balance Sheet Zacks Small Cap Research
12-Aug-14 05:11PM  Arrowhead Discloses First Human Hepatitis B Therapy Results at TheStreet
04:05PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 Business Wire
04:00PM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q3 2014 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
07-Aug-14 08:20AM  4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher at 24/7 Wall St.
04-Aug-14 09:55AM  Today's Dead Cat Bounce Stock Is Arrowhead Research (ARWR) at TheStreet
01-Aug-14 08:06AM  Biotech Stock Mailbag: Arrowhead, Catalyst Pharma at TheStreet -5.30%
31-Jul-14 04:05PM  Arrowhead to Report Fiscal 2014 Third Quarter Financial Results Business Wire
09:46AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Perilous Reversal" Stock at TheStreet
29-Jul-14 05:00AM  'Fast Money' Recap: Playing China Through U.S. Stocks at TheStreet +11.47%
28-Jul-14 08:55AM  5 Huge Biotech Catalysts Right Around the Corner for Top Stocks at 24/7 Wall St.
25-Jul-14 08:16AM  Alnylam And Benitec at Seeking Alpha
24-Jul-14 01:59PM  Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock at TheStreet
22-Jul-14 09:50AM  Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A Buying Opportunity? at Seeking Alpha
10-Jul-14 09:46AM  Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock at TheStreet
09-Jul-14 09:47AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +8.07%
05:00AM  'Fast Money' Recap: Waiting for the Dust to Settle at TheStreet
08-Jul-14 05:46PM  [video] Biotech buys right now at CNBC -8.06%
27-Jun-14 07:50AM  Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma PR Newswire
26-Jun-14 11:02AM  Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +5.96%
25-Jun-14 08:45AM  Arrowhead (ARWR): Current Price Does Not Reflect Value Zacks Small Cap Research -5.43%
24-Jun-14 01:04AM  Better Buy: Isis Pharmaceuticals vs. Arrowhead Research at Motley Fool -5.71%
23-Jun-14 09:52AM  Arrowhead Research (ARWR) Showing Signs Of Perilous Reversal Today at TheStreet
19-Jun-14 04:42PM  Why Arrowhead Research Corp. Shares Swooned at Motley Fool -7.34%
11:59AM  Arrowhead Announces New Clinical Candidate ARC-AAT for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease Business Wire
16-Jun-14 09:45AM  Today's Dead Cat Bounce Stock: Arrowhead Research (ARWR) at TheStreet +8.84%
07:30AM  Arrowhead Research Set to Join Russell 3000 Index Business Wire
13-Jun-14 05:41PM  Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520 Business Wire -9.74%
11-Jun-14 04:05PM  Arrowhead to Host Analyst Day to Discuss New Rare Liver Disease Candidate Business Wire
10-Jun-14 04:05PM  Arrowhead to Present at Upcoming Investor Conferences Business Wire
29-May-14 07:30AM  Arrowhead to Present at the Jefferies 2014 Global Healthcare Conference Business Wire
27-May-14 07:04PM  Biotech 101: RNA Drugs at Motley Fool +12.82%
12-May-14 09:45AM  Stock To Watch: Arrowhead Research (ARWR) In Perilous Reversal at TheStreet
07-May-14 12:38AM  Arrowhead Research's (ARWR) CEO Christopher Anzalone on Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
06-May-14 04:25PM  Q2 2014 Arrowhead Research Corp Earnings Conference Call (ARWR) Q2 2014 Results - Earnings Call Webcast at Seeking Alpha -6.75%
04:08PM  ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  Arrowhead to Present at Upcoming Scientific Conferences Business Wire
04:01PM  Arrowhead Reports Fiscal 2014 Second Quarter Financial Results Business Wire
03:57PM  ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q2 2014 ARROWHEAD RESH CORP Earnings Release - After Market Close CCBN
01-May-14 07:30AM  Arrowhead to Present at Deutsche Bank 39th Annual Health Care Conference Business Wire
30-Apr-14 06:00PM  Five Small Biotech Stocks Analysts Think Will Triple at Forbes
29-Apr-14 04:05PM  Arrowhead to Report Fiscal 2014 Second Quarter Financial Results Business Wire
09:22AM  Tiger Soup at Seeking Alpha
16-Apr-14 09:47AM  Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock at TheStreet +8.49%
Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company's product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and Adipotide, which is in Phase I clinical trial for the treatment for obesity and related metabolic disorders. Its platform technologies include Dynamic Polyconjugate platform, a RNA delivery system that addresses multiple organ systems and cell types, promotes multi-log gene knockdown, and induces endosomal escape; and Homing Peptides platform, a library of short peptides. The company also develops DPC-enabled RNAi therapeutic, a pre-clinical stage product to treat an undisclosed orphan liver disease. It also has research collaboration and license agreement with Shire AG to develop and commercialize targeted peptide-drug conjugates. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anzalone Christopher RichardPresident and CEOOct 15Buy6.3216,000101,120260,173Oct 15 05:31 PM
GIVEN DOUGLAS BDirectorSep 26Option Exercise2.192,0004,38022,000Sep 30 05:58 PM
GIVEN DOUGLAS BDirectorSep 26Sale15.242,00030,48020,000Sep 30 05:58 PM
GIVEN DOUGLAS BDirectorAug 15Option Exercise2.015,00010,05025,000Aug 19 05:15 PM
Myszkowski Kenneth AllenCFOAug 15Option Exercise6.3240,000252,850111,500Aug 19 05:15 PM
Myszkowski Kenneth AllenCFOAug 15Sale14.0240,000560,86071,500Aug 19 05:15 PM
GIVEN DOUGLAS BDirectorAug 15Sale13.905,00069,50120,000Aug 19 05:15 PM
McKenney CharlesDirectorJun 09Option Exercise2.3922,00052,48039,220Jun 10 09:28 PM
McKenney CharlesDirectorJun 09Sale14.3222,000315,00517,220Jun 10 09:28 PM
Myszkowski Kenneth AllenCFOFeb 12Option Exercise2.0116,00032,16087,500Feb 12 07:15 PM
Myszkowski Kenneth AllenCFOFeb 12Sale18.7716,000300,29071,500Feb 12 07:15 PM
FRYKMAN EDWARD WDirectorFeb 07Option Exercise10.005,00050,00027,000Feb 10 07:45 PM
FRYKMAN EDWARD WDirectorFeb 07Sale15.983,14850,29623,852Feb 10 07:45 PM